article thumbnail

FDA Approves First Flu Vaccine You Give Yourself at Home

Drugs.com

20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Administration on Friday approved FluMist nasal spray as the first influenza vaccine that can be. FRIDAY, Sept.

article thumbnail

FDA Approves First Flu Vaccine You Give Yourself at Home, FluMist

Drugs.com

20, 2024 -- The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Administration on Friday approved FluMist nasal spray as the first influenza vaccine that can be. FRIDAY, Sept.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Many older adults want RSV vaccine, poll shows

SCIENMAG: Medicine & Health

The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or RSV, now that brand-new vaccines have started to arrive at pharmacies and clinics.

Vaccine 68
article thumbnail

Walgreens Statement Regarding FDA Emergency Use Authorization of COVID-19 Vaccine

The Pharma Data

We will be collaborating with nearly 35,000 skilled nursing and assisted living facilities nationwide that have selected Walgreens as their vaccine provider. Walgreens ( www.walgreens.com ) is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. Nasdaq: WBA), a global leader in retail and wholesale pharmacy.

Vaccine 52
article thumbnail

McKesson Fills Initial Government Orders for Moderna’s COVID-19 Vaccine

The Pharma Data

government’s public-private partnership to deliver COVID-19 vaccines to Americans, and under the direction of the Centers for Disease Control and Prevention (CDC) , McKesson began distributing Moderna’s COVID-19 vaccines and the ancillary supply kits needed to administer them. as well as handling the distribution of vaccines.

article thumbnail

China’s CanSino Enrolls More Than 20,000 in Late-Stage COVID-19 Vaccine Trial | 2020-12-22

The Pharma Data

CanSino Biologics has enrolled more than 20,000 participants in a global phase 3 study of its COVID-19 vaccine candidate, Ad5-nCoV, co-developed with a research arm of the Chinese military. The adenovirus-based vaccine is one of five that China has progressed to phase 3 trials so far. Source link.

Vaccine 52
article thumbnail

U.S. to Get Fewer Vials of Pfizer COVID-19 Vaccine

The Pharma Data

to Get Fewer Vials of Pfizer COVID-19 Vaccine. 25, 2021 — Pfizer will provide fewer vials of its COVID-19 vaccine to the United States in the coming months after it was discovered that it had previously shipped extra doses. Professional. MONDAY, Jan. In December, U.S. Doing so requires a specialty syringe.

Vaccine 52